NCT06030713

Brief Summary

In this study, investigators seek to determine whether the timing of antibiotics given to mothers during an elective C-section affects the composition of their infant's gut microbiome. To do this, a randomized controlled trial (RCT) was carried out with women undergoing elective C-sections. These women were either given antibiotics before the skin incision (AB+) or after the umbilical cord was clamped (AB-).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 25, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 11, 2023

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

3.6 years

First QC Date

August 25, 2023

Last Update Submit

September 11, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Infant microbial species level differences between two groups

    Centered log ratio transformed relative abundance differences of bacterial species (relative abundance of \> 0.05% and present in at least 2 infants) between two interventional groups

    First 6 weeks of life

  • Infant Alpha Diversity differences between two groups

    Alpha Diversity difference measured by the Shannon Diversity Index of infant microbiome at species level between two interventional groups

    First 6 weeks of life

  • Infant Beta Diversity differences between two groups

    Beta Diversity difference in Aitchison distances between the two intervention groups

    First 6 weeks of life

  • Infant Antibiotic Resistance total gene load differences between two groups

    Infant Antibiotic Resistance total gene load differenced measured in RPKM between the two interventional groups

    First 6 weeks of life

Secondary Outcomes (1)

  • Number of participants with post c-section maternal wound infection

    First 6 weeks of life

Study Arms (2)

Cord clamped after antibiotic prophylaxis

ACTIVE COMPARATOR

Umbilical cord clamped after 1g of cephazolin

Drug: Cefazolin

Cord clamped before antibiotic prophylaxis

EXPERIMENTAL

Umbilical cord clamped before 1g of cephazolin

Drug: Cefazolin

Interventions

Cord clamping before or after antibiotic (cefazolin) prophylaxis

Also known as: DB01327, J01DB04
Cord clamped after antibiotic prophylaxisCord clamped before antibiotic prophylaxis

Eligibility Criteria

AgeUp to 1 Year
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Females undergoing elective CS at the UMCG
  • Gestational age in weeks equal to or above 38 weeks

You may not qualify if:

  • Cephalosporin allergy
  • Exposure to antibiotic agent 2 weeks before CS
  • Temperature \>37.5 C before CS
  • Pre-labour rupture of membranes
  • Emergency CS
  • No -20 freezer at home
  • No command of the Dutch language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Groningen

Groningen, 9713 GZ, Netherlands

Location

MeSH Terms

Conditions

Communicable Diseases

Interventions

Cefazolin

Condition Hierarchy (Ancestors)

InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cephalosporinsbeta-LactamsLactamsAmidesOrganic ChemicalsThiazinesSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Trishla Sinha, MD

    University Medical Center Groningen

    PRINCIPAL INVESTIGATOR
  • Alexandra Zhernakova, MD/PhD

    University Medical Center Groningen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Timing of umbilical cord clamping is different in the two arms. One gram of Cefazolin (once, intravenous) will be given to one group of women before skin incision compared to 1g cefazolin given to another group of women after umbilical cord clamping during an elective caesarean section.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2023

First Posted

September 11, 2023

Study Start

March 1, 2019

Primary Completion

October 1, 2022

Study Completion

March 1, 2023

Last Updated

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will share

The sequencing data of the microbiome will be available for other researchers via EGA

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will become available upon publication
Access Criteria
Must fill in the form that the data will be used for research purposes.

Locations